Journal profile · Urology & Nephrology
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
ISSN 1062-4821 · eISSN 1473-6543 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.03; JCR Q2 (journal website); hybrid open access; review 6–12 weeks (community reports); community-reported acceptance: moderate; 88 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management and Blood Pressure and Hypertension Studies, together about 33.8% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
A reader-friendly resource, Current Opinion in Nephrology and Hypertension provides an up-to-date account of the most important advances in the field of nephrology and hypertension. Each issue contains either two or three sections delivering a diverse and comprehensive coverage of all the key issues, including pathophysiology of hypertension, circulation and hemodynamics, and clinical nephrology. Current Opinion in Nephrology and Hypertension is an indispensable journal for the busy clinician, researcher or student.
Source: LetPub
Research area (LetPub): Urology & Nephrology
Editor-in-chief Maarten TaalPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Kidney Disease and DiabetesMedicine13.8%
- Dialysis and Renal Disease ManagementMedicine12.4%
- Blood Pressure and Hypertension StudiesMedicine7.6%
- Parathyroid Disorders and TreatmentsMedicine6.9%
- Renal Diseases and GlomerulopathiesMedicine6.9%
- Ion Transport and Channel RegulationBiochemistry, Genetics and Molecular Biology5.7%
- Renin-Angiotensin System StudiesMedicine4.8%
- Acute Kidney Injury ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · PERIPHERAL VASCULAR DISEASE · rank 36/100
- JCR Q2 · UROLOGY & NEPHROLOGY · rank 38/134
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.03LetPub ·
- Impact factor (publisher)
- 3.1Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 86LetPub ·
- h-index
- 126OpenAlex ·
- i10-index
- 2,056OpenAlex ·
- 2-year mean citedness
- 3.21OpenAlex ·
- Self-citation rate
- 3.2%LetPub ·
- Share of gold OA articles
- 13.85%LetPub ·
Volume
- Articles per year
- 71LetPub ·
Articles by year OpenAlex count · 3,304 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 66 | 20 | 24 |
| 2025 | 88 | 18 | 205 |
| 2024 | 89 | 36 | 552 |
| 2023 | 88 | 31 | 734 |
| 2022 | 85 | 38 | 824 |
| 2021 | 81 | 29 | 1,086 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 1062-4821
- Electronic ISSN
- 1473-6543
- Latest issue on the website
- Volume 35, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
What CAS zone is CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION in?
In the 2025 upgraded edition of the CAS Journal Ranking, CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION?
The latest impact factor listed by LetPub is 3.03; CiteScore 4.9, h-index 126.
How long does peer review take at CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION in?
The journal's website gives JCR Q2; by category, PERIPHERAL VASCULAR DISEASE Q2 (36/100), UROLOGY & NEPHROLOGY Q2 (38/134). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION?
According to LetPub and DOAJ records, CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is indexed in SCIE and Scopus.
Is CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION open access, and what is the APC?
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .